These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35055020)

  • 1. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.
    Tran BM; Grimley SL; McAuley JL; Hachani A; Earnest L; Wong SL; Caly L; Druce J; Purcell DFJ; Jackson DC; Catton M; Nowell CJ; Leonie L; Deliyannis G; Waters SA; Torresi J; Vincan E
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants.
    Chiu MC; Li C; Liu X; Song W; Wan Z; Yu Y; Huang J; Xiao D; Chu H; Cai JP; To KK; Yuen KY; Zhou J
    mBio; 2022 Aug; 13(4):e0194422. PubMed ID: 35938726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Human Nose Organoid Respiratory Virus Model: an
    Rajan A; Weaver AM; Aloisio GM; Jelinski J; Johnson HL; Venable SF; McBride T; Aideyan L; Piedra FA; Ye X; Melicoff-Portillo E; Yerramilli MRK; Zeng XL; Mancini MA; Stossi F; Maresso AW; Kotkar SA; Estes MK; Blutt S; Avadhanula V; Piedra PA
    mBio; 2021 Feb; 13(1):e0351121. PubMed ID: 35164569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of viral entry-associated genes modulated by inflammatory cytokines in the nasal epithelium.
    Noh HE; Rha MS; Jeong Y; Kim D; Seo JH; Kang M; Moon UY; Kim CH; Cho HJ
    J Med Virol; 2024 Sep; 96(9):e29913. PubMed ID: 39257039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.
    Ahn JH; Kim J; Hong SP; Choi SY; Yang MJ; Ju YS; Kim YT; Kim HM; Rahman MDT; Chung MK; Hong SD; Bae H; Lee CS; Koh GY
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34003804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In well-differentiated primary human bronchial epithelial cells, TGF-
    O'Sullivan MJ; Mitchel JA; Mwase C; McGill M; Kanki P; Park JA
    Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L246-L253. PubMed ID: 33174447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Nasal Epithelial Cells (hNECs ) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2.
    Tan KS; Gamage AM; Liu J
    Methods Mol Biol; 2022; 2452():213-224. PubMed ID: 35554910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant functional differences in differentiated Conditionally Reprogrammed (CRC)- and Feeder-free Dual SMAD inhibited-expanded human nasal epithelial cells.
    Awatade NT; Wong SL; Capraro A; Pandzic E; Slapetova I; Zhong L; Turgutoglu N; Fawcett LK; Whan RM; Jaffe A; Waters SA
    J Cyst Fibros; 2021 Mar; 20(2):364-371. PubMed ID: 33414087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
    Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
    Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Culture Differentiation and Proliferation Conditions Influence the
    Redman E; Fierville M; Cavard A; Plaisant M; Arguel MJ; Ruiz Garcia S; McAndrew EM; Girard-Riboulleau C; Lebrigand K; Magnone V; Ponzio G; Gras D; Chanez P; Abelanet S; Barbry P; Marcet B; Zaragosi LE
    Am J Respir Cell Mol Biol; 2024 Sep; 71(3):267-281. PubMed ID: 38843491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
    Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
    Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Modeling of SARS-CoV-2 Infection of
    Hao S; Ning K; Kuz CA; Vorhies K; Yan Z; Qiu J
    mBio; 2020 Nov; 11(6):. PubMed ID: 33158999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
    Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses.
    Liu X; Wu Y; Rong L
    Virol Sin; 2020 Jun; 35(3):280-289. PubMed ID: 32557270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
    Sims AC; Burkett SE; Yount B; Pickles RJ
    Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells.
    Sasaki M; Kishimoto M; Itakura Y; Tabata K; Intaruck K; Uemura K; Toba S; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    Biochem Biophys Res Commun; 2021 Nov; 577():146-151. PubMed ID: 34517212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culturing of human nasal epithelial cells at the air liquid interface.
    Müller L; Brighton LE; Carson JL; Fischer WA; Jaspers I
    J Vis Exp; 2013 Oct; (80):. PubMed ID: 24145828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.